AI assistant
Sending…
Protara Therapeutics, Inc. — Director's Dealing 2022
Feb 11, 2022
34057_dirs_2022-02-11_ffdafc6d-76c7-4e33-95c4-3a8974dbadbc.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 5 — Annual Statement of Changes in Beneficial Ownership
Issuer: Protara Therapeutics, Inc. (TARA)
CIK: 0001359931
Period of Report: 2021-12-31
Reporting Person: Shefferman Jesse (Director, CEO and President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-06-29 | Common Stock | G | 1536 | $0.00 | Disposed | 870889 | Direct |
| 2021-06-29 | Common Stock | G | 513 | $0.00 | Disposed | 870376 | Direct |
More from Protara Therapeutics, Inc.
Capital/Financing Update
2026
May 28
Capital/Financing Update
2026
May 13
Interim / Quarterly Report
2026
May 13
Report Publication Announcement
2026
May 13
Regulatory Filings
2026
Mar 30
Regulatory Filings
2026
Feb 24
Capital/Financing Update
2026
Feb 2
Director's Dealing
2026
Jan 27
Director's Dealing
2026
Jan 27
Director's Dealing
2026
Jan 27